当前位置: X-MOL 学术J. Hepato Biliary Pancreat. Sci. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Role of postoperative adjuvant therapy in resected invasive intraductal papillary mucinous neoplasm of the pancreas: A multicenter external validation
Journal of Hepato-Biliary-Pancreatic Sciences ( IF 3 ) Pub Date : 2021-05-24 , DOI: 10.1002/jhbp.996
Munseok Choi 1 , Jae Uk Chong 2 , Ho Kyoung Hwang 3 , Hyung-Il Seo 4 , Kwangho Yang 5 , Je Ho Ryu 5 , Younghoon Roh 6 , Dong Hyun Kim 7 , Jin Ho Lee 2 , Woo Jung Lee 3 , Sung Hoon Choi 8 , Chang Moo Kang 3
Affiliation  

Adjuvant therapy is beneficial in prolonging survival in patients with pancreatic ductal adenocarcinoma (PDAC). However, no clear guidelines are available on the oncologic effect of adjuvant therapy in resected invasive intraductal papillary mucinous neoplasms (inv-IPMN).

中文翻译:

术后辅助治疗在胰腺浸润性导管内乳头状黏液性肿瘤切除中的作用:多中心外部验证

辅助治疗有利于延长胰腺导管腺癌 (PDAC) 患者的生存期。然而,关于辅助治疗在切除的浸润性导管内乳头状黏液性肿瘤 (inv-IPMN) 中的肿瘤学效果没有明确的指南。
更新日期:2021-05-24
down
wechat
bug